Evidence map›Paper›PMID 41428877›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Multicolor photoreactions of the red light-activated channelrhodopsin Chrimson.

Johannes Vierock, Joel C D Kaufmann, Lukas Faiß, Linda Tillert, Benjamin S Krause, Paul Fischer, Thi Bich Thao Nguyen, Dietmar Schmitz, Benjamin R Rost, Franz Bartl and 1 more

Erratum issuedAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Johannes Vierock *Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Neurosciences Research Center, Berlin 10117, Germany.ORCID 0000-0001-7368-5539
Joel C D Kaufmann *Institute of Biology, Biophysical Chemistry, Humboldt-Universität zu Berlin, Berlin 10115, Germany.
Lukas Faiß *Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Neurosciences Research Center, Berlin 10117, Germany.
Linda TillertCharité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Neurosciences Research Center, Berlin 10117, Germany.
Benjamin S KrauseInstitute of Biology, Experimental Biophysics, Humboldt-Universität zu Berlin, Berlin 10115, Germany.
Paul FischerInstitute of Biology, Experimental Biophysics, Humboldt-Universität zu Berlin, Berlin 10115, Germany.
Thi Bich Thao NguyenInstitute of Biology, Experimental Biophysics, Humboldt-Universität zu Berlin, Berlin 10115, Germany.
Dietmar SchmitzCharité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Neurosciences Research Center, Berlin 10117, Germany.ORCID 0000-0003-2741-5241
Benjamin R RostCharité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Neurosciences Research Center, Berlin 10117, Germany.
Franz BartlInstitute of Biology, Biophysical Chemistry, Humboldt-Universität zu Berlin, Berlin 10115, Germany.
Peter HegemannInstitute of Biology, Experimental Biophysics, Humboldt-Universität zu Berlin, Berlin 10115, Germany.ORCID 0000-0003-3589-6452

Funding

Deutsche Forschungsgemeinschaft (DFG) 221545957Deutsche Forschungsgemeinschaft (DFG) 327654276Deutsche Forschungsgemeinschaft (DFG) 425994138Deutsche Forschungsgemeinschaft (DFG) EXC-2049-390688087EC | ERC | HORIZON EUROPE European Research Council (ERC) 810580Einstein Stiftung Berlin (Einstein_Berlin) EZ-1014-226
6 · The paper itself

Abstract

Channelrhodopsins are light-gated ion channels that are used in modern neurosciences for the precise control of cellular ion fluxes by light. With a peak absorption at 585 nm, Chrimson is the most red-shifted cation-conducting ChR. It is frequently employed in multicolor experiments alongside blue light-sensitive optogenetic tools and is so far the only light-gated ion channel successfully applied in human vision restoration. However, its photoresponses to different wavelengths have not been thoroughly characterized. In this study, we identify multiple interconvertible dark states of Chrimson with distinct absorption and photokinetic properties. Combining electrophysiology and spectroscopy with optogenetic experiments in neurons, we unveil that this dark state heterogeneity is based on distinct protonation dynamics of the counterion complex and alternative retinal isomerization. In neurons, prolonged red illumination reduces Chrimson's red light sensitivity, which is reflected by a blue shift of the action spectrum. Blue light pulses reverse this shift and increase the excitability in subsequent red-light flashes. This understanding of wavelength-dependent photoreactions in Chrimson will improve the design of multicolor optogenetic experiments and inform strategies for optimizing Chrimson for therapeutic applications.

Indexed as

ChannelrhodopsinsLightAnimalsHEK293 CellsHumansNeuronsOptogeneticsRed LightChannelrhodopsinschannelrhodopsinsChrimsonFTIR spectroscopyoptogeneticsretinal prosthesis

Identifiers

PMID41428877
PMCPMC12772191

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.